Form 8-K - Current report:
SEC Accession No. 0001493152-23-021998
Filing Date
2023-06-21
Accepted
2023-06-21 16:05:20
Documents
19
Period of Report
2023-06-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49831
2 ex1-1.htm EX-1.1 481641
3 ex3-1.htm EX-3.1 33431
4 ex3-2.htm EX-3.2 110233
5 ex99-1.htm EX-99.1 9859
6 ex99-2.htm EX-99.2 11887
7 ex99-1_001.jpg GRAPHIC 19727
8 ex99-2_001.jpg GRAPHIC 19727
  Complete submission text file 0001493152-23-021998.txt   1069488

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE aztr-20230615.xsd EX-101.SCH 2962
10 XBRL LABEL FILE aztr-20230615_lab.xml EX-101.LAB 34240
11 XBRL PRESENTATION FILE aztr-20230615_pre.xml EX-101.PRE 22361
13 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3705
Mailing Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405
Business Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405 (203) 489-0183
Azitra Inc (Filer) CIK: 0001701478 (see all company filings)

EIN.: 464478536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41705 | Film No.: 231029827
SIC: 2834 Pharmaceutical Preparations